Mersana Therapeutics forecasted future revenue decline contr...
Mersana Therapeutics forecasted future revenue decline contributes to lower P/S ratio, limiting strong rise potential in share prices. The market expects performance drop, keeping P/S suppressed. For P/S to avoid further fall, top-line growth needs improvement.
Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4953
Followers
0
Following
11K
Visitors
Follow